COGNISANT Boosts Short-term Memory in Older Adults: Study
A new strategy that combines online cognitive therapeutic games with a noninvasive brain stimulation technique – called COGNISANT – may…
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
A new strategy that combines online cognitive therapeutic games with a noninvasive brain stimulation technique – called COGNISANT – may…
Researchers have developed a software that can accurately identify people with Parkinson’s disease or multiple sclerosis (MS) from…
Muna Therapeutics has received a $4.9 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to advance…
Two clinically-proven speech therapy programs tailored to Parkinson’s disease patients, SPEAK OUT! and The LOUD Crowd, are now available at the…
The risk of developing dementia appears to be higher among people with Parkinson’s disease when compared to age and…
The U.S. Food and Drug Administration (FDA) wants more information before it will approve Supernus Pharmaceuticals’ new drug application…
Biotech company Innervace — a spinoff from the University of Pennsylvania — has raised up to $40 million to support…
A protein “traffic jam” inside nerve cells promotes the buildup of shorter and toxic tau — a protein that forms…
AC Immune will use a new $500,000 grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to…
SynAgile announced the completion of a Phase 2 clinical trial evaluating DopaFuse, its noninvasive system for the continuous oral delivery…
Get regular updates to your inbox.